You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics among patients with and without adverse outcomes

From: Developing a scoring tool to estimate the risk of deterioration for normotensive patients with acute pulmonary embolism on admission

  All patients Adverse outcomes p-value
(n = 845) Yes (n = 81) No (n = 764)
Sex (male) 420 (49.7%) 42(51.9%) 378 (49.5%) 0.68
Age (years) 60.05 ± 15.43 59.36 ± 15.74 60.12 ± 15.40 0.93
Heart rate (beats/min) 86.57 ± 17.81 108.64 ± 22.84 84.23 ± 15.45  < 0.001
Systolic pressure (mmHg) 124.33 ± 18.26 115.22 ± 19.64 125.30 ± 17.85  < 0.001
RV dysfunction 240(28.4%) 59(72.8%) 181(23.7%)  < 0.001
c-Tn I (μg/L) 0.11 ± 0.47 0.25 ± 0.49 0.091 ± 0.46  < 0.001
NT-pro BNP (pg/mL) 1,547.12 ± 3,652.06 131,039 ± 3,255.93 3,779.92 ± 5,832.71  < 0.001
CPA embolism 209 (24.7%) 45 (55.6%) 164 (22.0%)  < 0.001
Saddle-CPA embolism 62 (7.3%) 17 (21.0%) 45 (5.9%)  < 0.001
RV short-axis diameter (mm) 39.21 ± 7.42 44.70 ± 8.53 38.62 ± 7.05  < 0.001
LV short-axis diameter (mm) 40.76 ± 7.30 33.68 ± 6.91 41.51 ± 6.94  < 0.001
RV4-chamber diameter (mm) 36.38 ± 7.37 42.64 ± 10.28 35.72 ± 6.67  < 0.001
LV 4-chamber diameter (mm) 39.47 ± 7.36 31.63 ± 7.09 40.30 ± 6.88  < 0.001
RA 4-chamber diameter (mm) 45.44 ± 9.34 52.38 ± 11.72 44.70 ± 8.74  < 0.001
LA 4-chamber diameter (mm) 34.83 ± 8.52 29.18 ± 8.00 35.43 ± 8.35  < 0.001
RV/LV short-axis diameter ratio 1.00 ± 0.30 1.38 ± 0.40 0.96 ± 0.25  < 0.001
RV/LV 4-chamber diameter ratio 0.96 ± 0.31 1.44 ± 0.59 0.90 ± 0.20  < 0.001
RA/LA 4-chamber diameter ratio 1.39 ± 0.52 1.97 ± 0.87 1.33 ± 0.42  < 0.001
Bova score
 Low risk 681 (75.9%) 33 (40.7%) 648 (84.4%)  < 0.001
 Intermediate-low risk 102 (12.1%) 17 (20.7%) 85 (11.1%) 0.009
 Intermediate-high risk 62 (7.3%) 31 (38.3%) 31 (4.1%)  < 0.001
2019 ESC algorithm
 Low risk 503 (59.5%) 17 (21.0%) 486 (63.6%)  < 0.001
 Intermediate-low risk 172 (20.4%) 14 (17.3%) 158 (20.7%) 0.47
 Intermediate-high risk 170 (20.1%) 50 (61.7%) 120 (15.7%)  < 0.001
  1. c Tn-I cardiac troponin I, NT-pro BNP N-terminal pro-brain natriuretic peptide, CPA central pulmonary artery, RV right ventricle, LV left ventricle, RA right atrium, LA left atrium, ESC European Society of Cardiology